Imunon, Inc.
IMNN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | – | -100% | 0% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | – | – | 100% | 100% |
| R&D Expenses | $12 | $11 | $12 | $11 |
| G&A Expenses | $7 | $10 | $14 | $11 |
| SG&A Expenses | $7 | $10 | $14 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $21 | $25 | $22 |
| Operating Income | -$19 | -$21 | -$25 | -$21 |
| % Margin | – | – | -4,984.3% | -4,201.4% |
| Other Income/Exp. Net | $1 | $0 | -$13 | -$1 |
| Pre-Tax Income | -$19 | -$21 | -$37 | -$22 |
| Tax Expense | $0 | -$1 | -$2 | -$1 |
| Net Income | -$19 | -$20 | -$36 | -$21 |
| % Margin | – | – | -7,179.6% | -4,153.9% |
| EPS | -21.104 | -28.141 | -65.552 | -748.772 |
| % Growth | 25% | 57.1% | 91.2% | – |
| EPS Diluted | -21.104 | -28.141 | -65.552 | -748.772 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $5 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$18 | -$20 | -$32 | -$21 |
| % Margin | – | – | -6,341% | -4,176% |